PR94087

CLAMART, France, Jan. 17, 2022 /PRNewswire=KYODO JBN/ --

MicroPort CRM, a pioneering company in the field of Cardiac Rhythm Management,

headquartered in France, recently received PMDA Japanese regulation agency

approval for its latest range of implantable pacemakers, Alizea. The devices

are equipped with Bluetooth technology for streamlined remote monitoring when

paired with MicroPort CRM's SmartView Connect home monitor, already approved in

Japan.  

Alizea pacemakers allow cardiologists to monitor devices remotely. The

SmartView Connect home monitor is designed to be placed at the patient's

bedside to allow for the regular transmission of detailed reports to the

cardiologist on the functioning of the pacing system, removing the need for

patients to visit the hospital for simple routine examinations, and thus

reducing the burden on the healthcare system. Alizea pacemakers and the

SmartView Connect home monitor work together to provide the cardiologist with

timely alerts and transmissions triggered by patients when they present

symptoms, leading to faster and more efficient patient care.

Noboru Shimizu, VP of MicroPort CRM Sales Japan, commented, "Around 64,000

patients are implanted with a pacemaker each year in Japan, and coupled with

the difficulties that have arisen from the current health crisis, there is a

growing need to monitor patients remotely, without them having to travel.

Thanks to Alizea pacemakers and its SmartView Connect monitor, we are

positioning ourselves in the Japanese market with the very best in cardiac

pacing. I am convinced that this will allow us to strengthen our presence in

Japan."

Benoît Clinchamps, President of MicroPort CRM, noted, "We successfully launched

Alizea in Europe in June 2021, and Japan is the second region to benefit from

its advanced technological functions. As part of our commitment to improve the

lives of as many patients as possible, and to support healthcare professionals

in their mission, we will continue to deploy Alizea and Smartview Connect

around the world."

About MicroPort CRM

MicroPort CRM is a pioneering company in the field of Cardiac Rhythm Management

(CRM), and a subsidiary of MicroPort Scientific Corporation (stock code:

00853.HK), with world headquarters in Clamart, near Paris, France. Through its

long-standing expertise in CRM, MicroPor CRM develops, manufactures and markets

cardiac pacemakers, implantable cardiac defibrillators, cardiac

resynchronization systems and ECG diagnostic solutions for the management of

cardiac rhythm disorders and heart failure, globally.

For more information, please refer to www.microport.com

SOURCE:  MicroPort

Image Attachments Links:

   Link: http://asianetnews.net/view-attachment?attach-id=412927

   Caption: Alizea Bluetooth Pacemaker

   Link: http://asianetnews.net/view-attachment?attach-id=412928